Read more:
Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments
Author Archives: Fredricko
NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to…
SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial
Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain
Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of EDSIVO™ (celiprolol) for the Treatment of Vascular Ehlers-Danlos…
Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board
See the original post:
Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%
See the original post here:
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%
CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting
Read the original here:
CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting
CENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer
Eliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Read the original here:
Sanofi: Information concerning the total number of voting rights and shares – May 2022
Spero Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Tebipenem HBr New Drug Application
Acerus Announces Voting Results for the 2022 Annual Meeting
Agra Ventures Announces Results of its Annual General & Special Meeting
Read this article:
Agra Ventures Announces Results of its Annual General & Special Meeting